Land: Nederland
Taal: Nederlands
Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
ARIPIPRAZOL 30 mg/stuk
Sandoz B.V. Veluwezoom 22 1327 AH ALMERE
N05AX12
ARIPIPRAZOL 30 mg/stuk
Orodispergeerbare tablet
ARABISCHE GOM (E 414) ; ASPARTAAM (E 951) ; BENZYLALCOHOL (E 1519) ; CELLULOSE, MICROKRISTALLIJN (E 460(i)) ; CROSCARMELLOSE NATRIUM (E 468) ; IJZEROXIDE ROOD (E 172) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; MALTODEXTRINE ; PROPYLEENGLYCOL (E 1520) ; SILICIUMDIOXIDE (E 551) ; VANILLESMAAKSTOF, ARABISCHE GOM (E 414) ; ASPARTAAM (E 951) ; BENZYLALCOHOL (E 1519) ; CELLULOSE, MICROKRISTALLIJN (E 460) ; CROSCARMELLOSE NATRIUM (E 468) ; IJZEROXIDE ROOD (E 172) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; MALTODEXTRINE ; PROPYLEENGLYCOL (E 1520) ; SILICIUMDIOXIDE (E 551) ; VANILLESMAAKSTOF,
Oraal gebruik
Aripiprazole
Hulpstoffen: ARABISCHE GOM (E 414); ASPARTAAM (E 951); BENZYLALCOHOL (E 1519); CELLULOSE, MICROKRISTALLIJN (E 460); CROSCARMELLOSE NATRIUM (E 468); IJZEROXIDE ROOD (E 172); LACTOSE 1-WATER; MAGNESIUMSTEARAAT (E 470b); MALTODEXTRINE; PROPYLEENGLYCOL (E 1520); SILICIUMDIOXIDE (E 551); VANILLESMAAKSTOF;
2015-09-02
Sandoz B.V. Page 1/13 Aripiprazol Sandoz ® 10, 15, 30 mg orodispergeerbare tabletten RVG 115588, 115589, 115590 1313-V11B 1.3.1.3 Bijsluiter Januari 2023 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ARIPIPRAZOL SANDOZ ® 10 MG ORODISPERGEERBARE TABLETTEN ARIPIPRAZOL SANDOZ ® 15 MG ORODISPERGEERBARE TABLETTEN ARIPIPRAZOL SANDOZ ® 30 MG ORODISPERGEERBARE TABLETTEN aripiprazole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What [Nationally completed name] is and what it is used for 2. What you need to know before you take [Nationally completed name] 3. How to take [Nationally completed name] 4. Possible side effects 5 How to store [Nationally completed name] 6. Contents of the pack and other information 1. WHAT [NATIONALLY COMPLETED NAME] IS AND WHAT IT IS USED FOR [Nationally completed name] contains the active substance aripiprazole and belong to a group of medicines called antipsychotics. It is used to treat adults and adolescents aged 15 years and older who suffer from a disease characterised by symptoms such as hearing, seeing or sensing things which are not there, suspiciousness, mistaken beliefs, incoherent speech and behaviour and emotional flatness. People with this condition may also feel depressed, guilty, anxious or tense. [Nationally completed name] is used to treat adults and adolescents aged 13 years and older who suffer from a condition with symptoms such as feeling "high", having excessive amounts of energy, needing much less sleep than usual, talking very quickly with racing ideas Lees het volledige document
Sandoz B.V. Page 1/28 Aripiprazol Sandoz 10, 15, 30 mg orodispergeerbare tabletten RVG 115588, 115589, 115590 1311-V10A 1.3.1.1 Samenvatting van de Productkenmerken Januari 2023 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Aripiprazol Sandoz 10 mg orodispergeerbare tabletten Aripiprazol Sandoz 15 mg orodispergeerbare tabletten Aripiprazol Sandoz 30 mg orodispergeerbare tabletten 2. QUALITATIVE AND QUANTITATIVE COMPOSITION _10 mg: _ Each orodispersible tablet contains 10 mg of aripiprazole. Excipients with known effect Each orodispersible tablet contains 90.30 mg of lactose (as monohydrate), 1.0 mg of aspartame, and up to 0.0036 mg of benzyl alcohol. _15 mg: _ Each orodispersible tablet contains 15 mg of aripiprazole. Excipients with known effect Each orodispersible tablet contains 135.46 mg of lactose (as monohydrate), 1.5 mg of aspartame, and up to 0.0054 mg of benzyl alcohol. _30 mg: _ Each orodispersible tablet contains 30 mg of aripiprazole. Excipients with known effect Each orodispersible tablet contains 270.90 mg of lactose (as monohydrate), 3.0 mg of aspartame, and up to 0.0108 mg of benzyl alcohol. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Orodispersible tablet. _10 mg: _ Sandoz B.V. Page 2/28 Aripiprazol Sandoz 10, 15, 30 mg orodispergeerbare tabletten RVG 115588, 115589, 115590 1311-V10A 1.3.1.1 Samenvatting van de Productkenmerken Januari 2023 Round, flat, pink tablets, engraved with ‘10’ on one side and plain on the other with a diameter of 8.0 mm ± 0.1 mm. _15 mg: _ Round, flat, yellow tablets, engraved with ‘15’ on one side and plain on the other with a diameter of 9.0 mm ± 0.1 mm. _30 mg: _ Round, flat, pink tablets, engraved with ‘30’ on one side and plain on the other with a diameter of 10.0 mm ± 0.1 mm. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS [Nationally completed name] is indicated for the treatment of schizophrenia in adults and in adolescents aged 15 years and older. [Nationally completed name] is indicated for t Lees het volledige document